MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies.

about

miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer

P2860

Q58605694-656A56FD-9DB0-4D86-9FA9-E8CC8FF0D6E3

P2860

MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies.

Item

http://www.wikidata.org/entity/Q38648606

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies.

@en

type

Item

label

MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies.

@en

prefLabel

MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies.

@en

P1476

MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies

@en

P2093

Chandra Bartholomeusz

http://www.w3.org/2001/XMLSchema#string

Juliana M Taliaferro

http://www.w3.org/2001/XMLSchema#string

Mary Kathryn Pitner

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family

CDC25B phosphorylated by pEg3 localizes to the centrosome and the spindle poles at mitosis

Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation

MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption

Kinase associated-1 domains drive MARK/PAR1 kinases to membrane targets by binding acidic phospholipids

Positive regulation of apoptosis signal-regulating kinase 1 signaling by ZPR9 protein, a zinc finger protein

Substrate specificity and activity regulation of protein kinase MELK

Phosphorylation of a novel zinc-finger-like protein, ZPR9, by murine protein serine/threonine kinase 38 (MPK38)

Anillin binds nonmuscle myosin II and regulates the contractile ring

Cancerous stem cells can arise from pediatric brain tumors

P304

849-859

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14728222.2017.1363183

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kevin N Dalby

P577

2017-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28764577

http://www.w3.org/2001/XMLSchema#string

MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies.

about

P2860

P2860

MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698